JB
KYTH

Julian Baker’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Julian Baker’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-387,741
Closed -$29.2M – 138
2015
Q2 		$29.2M Buy
387,741
+33,476
+9% +$1.79M 0.26% 39
2015
Q1 		$17.8M Buy
354,265
+68,010
+24% +$2.85M 0.15% 44
2014
Q4 		$9.93M Sell
286,255
-25,000
-8% -$872K 0.1% 48
2014
Q3 		$10.2M Hold
311,255
– – 0.13% 45
2014
Q2 		$11.9M Hold
311,255
– – 0.15% 44
2014
Q1 		$12.4M Sell
311,255
-1,936
-0.6% -$86.6K 0.16% 44
2013
Q4 		$11.7M Buy
313,191
+48,191
+18% +$2M 0.16% 44
2013
Q3 		$12.1M Buy
265,000
+100,000
+61% +$2.99M 0.17% 38
2013
Q2 		$4.46M Buy
+165,000
New +$3.78M 0.09% 50

Other funds holding KYTH

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Julian Baker's KYTH Position: Q3 2015 in Review

Julian Baker sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q3 2015, closing a stake of 387,741 shares — an estimated $29.2M sold.

Julian Baker first reported a position in KYTH in Q2 2013 and held it in 9 quarters. The position peaked at $29.2M in Q2 2015. 143 funds tracked by Wall St. Rank hold KYTH as of Q3 2015.

  • Julian Baker reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q3 2015 after selling out during the quarter.
  • Julian Baker sold 387,741 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q3 2015, an estimated $29.2M.
  • Julian Baker first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 9 quarters.
  • Julian Baker's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $29.2M in Q2 2015.
  • 143 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q3 2015.

Based on Baker Bros. Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.